Cargando…
Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers
BACKGROUND: Up to now, only limited data on long-term medical treatment in congenital hyperinsulinism (CHI) is available. Moreover, most of the drugs used in CHI are therefore not approved. We aimed to assemble more objective information on medical treatment in CHI with regard to type and duration,...
Autores principales: | Welters, Alena, Lerch, Christian, Kummer, Sebastian, Marquard, Jan, Salgin, Burak, Mayatepek, Ertan, Meissner, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660626/ https://www.ncbi.nlm.nih.gov/pubmed/26608306 http://dx.doi.org/10.1186/s13023-015-0367-x |
Ejemplares similares
-
Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism
por: Corda, Heike, et al.
Publicado: (2017) -
Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism
por: Roeper, Marcia, et al.
Publicado: (2020) -
Anxiety, depression, and quality of life in parents of children with congenital hyperinsulinism
por: Roeper, Marcia, et al.
Publicado: (2022) -
Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism
por: Welters, Alena, et al.
Publicado: (2018) -
Health Behaviour in Children and Adolescents with Type 1 Diabetes Compared to a Representative Reference Population
por: Kummer, Sebastian, et al.
Publicado: (2014)